Anastasios Mpotsaris1, Martin Skalej2, Oliver Beuing2, Bernd Eckert3, Daniel Behme4, Werner Weber5. 1. Department of Radiology and Neuroradiology, University Hospital of Cologne, Germany anastasios.mpotsaris@uk-koeln.de. 2. Institute of Neuroradiology, University Hospital of Magdeburg, Germany. 3. Department of Neuroradiology, Asklepios Clinic Altona, Germany. 4. Department of Neuroradiology, University Medical Center, Germany. 5. Department of Radiology and Neuroradiology, University Medical Center Langendreer - Knappschaftskrankenhaus, Ruhr-University Bochum, Germany.
Abstract
BACKGROUND AND PURPOSE: The purpose of this article is to report on the long-term success rates of Silk flow-diverter (FD) treatment in a multicenter prospective study for the treatment of complex aneurysms. METHODS: Between May 2008 and January 2011, all consecutive patients featuring complex intracranial aneurysms eligible for FD treatment with the Silk in three neurovascular centers were included. Clinical and imaging data were assessed during hospitalization and follow-up. RESULTS: Five patients were initially asymptomatic, 20 patients showed various neurological symptoms. Twenty-eight FDs were implanted in 25 patients treating 28 aneurysms. The immediate procedure-related morbidity was 8% (two of 25), mortality 0%. One procedure-related death was observed during follow-up (in-stent thrombosis). Compared to the immediate result nearly two of three aneurysms improved during follow-up; all angiographically confirmed inflow changes took place within six months after treatment. Final anatomic outcome in 24 aneurysms of 22 patients comprised 14 (59%) with complete occlusion, seven (29%) with a neck remnant, two (8%) with residual filling <50%, none with residual filling >50% and one (4%) unchanged in comparison to its pretreatment status. Postinterventional recanalizations were seen in three of 13 (23%) aneurysms treated with FD alone; none were observed in 15 aneurysms treated with adjunctive coiling. CONCLUSION: Anatomic presentation and location are key for successful FD treatment. The rate of successful occlusion increases during follow-up. Postinterventional monitoring for at least six months is paramount, as anatomic outcome is not reliably predictable and recanalizations may occur in initially completely occluded aneurysms.
BACKGROUND AND PURPOSE: The purpose of this article is to report on the long-term success rates of Silk flow-diverter (FD) treatment in a multicenter prospective study for the treatment of complex aneurysms. METHODS: Between May 2008 and January 2011, all consecutive patients featuring complex intracranial aneurysms eligible for FD treatment with the Silk in three neurovascular centers were included. Clinical and imaging data were assessed during hospitalization and follow-up. RESULTS: Five patients were initially asymptomatic, 20 patients showed various neurological symptoms. Twenty-eight FDs were implanted in 25 patients treating 28 aneurysms. The immediate procedure-related morbidity was 8% (two of 25), mortality 0%. One procedure-related death was observed during follow-up (in-stent thrombosis). Compared to the immediate result nearly two of three aneurysms improved during follow-up; all angiographically confirmed inflow changes took place within six months after treatment. Final anatomic outcome in 24 aneurysms of 22 patients comprised 14 (59%) with complete occlusion, seven (29%) with a neck remnant, two (8%) with residual filling <50%, none with residual filling >50% and one (4%) unchanged in comparison to its pretreatment status. Postinterventional recanalizations were seen in three of 13 (23%) aneurysms treated with FD alone; none were observed in 15 aneurysms treated with adjunctive coiling. CONCLUSION: Anatomic presentation and location are key for successful FD treatment. The rate of successful occlusion increases during follow-up. Postinterventional monitoring for at least six months is paramount, as anatomic outcome is not reliably predictable and recanalizations may occur in initially completely occluded aneurysms.
Authors: J Berge; A Biondi; P Machi; H Brunel; L Pierot; J Gabrillargues; K Kadziolka; X Barreau; V Dousset; A Bonafé Journal: AJNR Am J Neuroradiol Date: 2012-02-02 Impact factor: 3.825
Authors: Z Kulcsár; E Houdart; A Bonafé; G Parker; J Millar; A J P Goddard; S Renowden; G Gál; B Turowski; K Mitchell; F Gray; M Rodriguez; R van den Berg; A Gruber; H Desal; I Wanke; D A Rüfenacht Journal: AJNR Am J Neuroradiol Date: 2010-11-11 Impact factor: 3.825
Authors: M Leonardi; L Cirillo; F Toni; M Dall'olio; C Princiotta; A Stafa; L Simonetti; R Agati Journal: Interv Neuroradiol Date: 2011-10-17 Impact factor: 1.610
Authors: Zsolt Kulcsár; Ulrike Ernemann; Stephan G Wetzel; Alexander Bock; Sophia Goericke; Vasilis Panagiotopoulos; Michael Forsting; Daniel A Ruefenacht; Isabel Wanke Journal: Stroke Date: 2010-07-08 Impact factor: 7.914
Authors: I Szikora; Z Berentei; Z Kulcsar; M Marosfoi; Z S Vajda; W Lee; A Berez; P K Nelson Journal: AJNR Am J Neuroradiol Date: 2010-02-11 Impact factor: 3.825
Authors: L Cirillo; M Leonardi; M Dall'olio; C Princiotta; A Stafa; L Simonetti; F Toni; R Agati Journal: Interv Neuroradiol Date: 2012-12-03 Impact factor: 1.610
Authors: H Luecking; T Engelhorn; S Lang; P Goelitz; S Kloska; K Roessler; A Doerfler Journal: AJNR Am J Neuroradiol Date: 2017-01-19 Impact factor: 3.825
Authors: Francesco Briganti; Giuseppe Leone; Lorenzo Ugga; Mariano Marseglia; Antonio Macera; Andrea Manto; Luigi Delehaye; Maurizio Resta; Mariachiara Resta; Nicola Burdi; Nunzio Paolo Nuzzi; Ignazio Divenuto; Ferdinando Caranci; Mario Muto; Domenico Solari; Paolo Cappabianca; Francesco Maiuri Journal: J Neurointerv Surg Date: 2016-07-20 Impact factor: 5.836
Authors: Pervinder Bhogal; Victoria Hellstern; Hansjörg Bäzner; Oliver Ganslandt; Hans Henkes; Marta Aguilar Pérez Journal: Front Neurol Date: 2017-08-07 Impact factor: 4.003
Authors: P Bhogal; R Martinez Moreno; O Ganslandt; H Bäzner; H Henkes; M Aguilar Perez Journal: J Neurointerv Surg Date: 2016-10-27 Impact factor: 5.836
Authors: Marta Aguilar Pérez; Elina Henkes; Victoria Hellstern; Carmen Serna Candel; Christina Wendl; Hansjörg Bäzner; Oliver Ganslandt; Hans Henkes Journal: Oper Neurosurg (Hagerstown) Date: 2021-03-15 Impact factor: 2.703
Authors: Pervinder Bhogal; Elina Henkes; Stefan Schob; Muhammad AlMatter; Victoria Hellstern; Hansjörg Bäzner; Oliver Ganslandt; Hans Henkes; Marta Aguilar Pérez Journal: Surg Neurol Int Date: 2018-10-30
Authors: Tim Lenz-Habijan; P Bhogal; Marcus Peters; Albrecht Bufe; Rosa Martinez Moreno; Catrin Bannewitz; Hermann Monstadt; Hans Henkes Journal: Cardiovasc Intervent Radiol Date: 2018-07-23 Impact factor: 2.740